Nuveen’s Akcea Therapeutics Inc AKCA Stock Holding History

Nuveen’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-101,322	Closed	-$1.84M	–	3407
2020 Q3	$1.84M	Buy	101,322 +28,235	+39%	+$401K	﹤0.01%	2423
2020 Q2	$1M	Sell	73,087 -4,431	-6%	-$68.4K	﹤0.01%	2623
2020 Q1	$1.11M	Buy	77,518 +15,938	+26%	+$262K	﹤0.01%	2476
2019 Q4	$1.04M	Sell	61,580 -2,812	-4%	-$52.3K	﹤0.01%	2671
2019 Q3	$991K	Sell	64,392 -1,030	-2%	-$21.9K	﹤0.01%	2711
2019 Q2	$1.53M	Buy	+65,422	New	+$1.62M	﹤0.01%	2559

Nuveen's AKCA Position: Q4 2020 in Review

Nuveen sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 101,322 shares — an estimated $1.84M sold.

Nuveen first reported a position in AKCA in Q2 2019 and held it in 6 quarters. The position peaked at $1.84M in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Nuveen reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Nuveen sold 101,322 Akcea Therapeutics Inc shares in Q4 2020, an estimated $1.84M.
Nuveen first reported a position in Akcea Therapeutics Inc in Q2 2019 and held it in 6 quarters.
Nuveen's Akcea Therapeutics Inc position peaked at $1.84M in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.